2017 Symposium Features Notable Research Advances in Palliative and Supportive Care

For immediate release
October 27, 2017

Contact

Ashley Yum
571-483-1376

SAN DIEGO – Five studies exploring noteworthy issues in palliative care will be presented at the 2017 Palliative and Supportive Care in Oncology Symposium, taking place October 27-28 at the Manchester Grand Hyatt in San Diego, California. These key abstracts explore several approaches for improving quality of life and quality of care for people with cancer, as well as survivors of cancer.

Palliative and supportive care experts are available to comment on the studies below.
 

Abstract 46:
The PULSES project: Teaching the vital elements of code status discussions to oncology residents.

Poster Session B
Saturday, October 28, 2017: 7:00 - 7:55 a.m. PT,
Saturday, October 28, 2017: 11:45 a.m. - 1:15 p.m. PT          
Manchester Grand Hyatt, Grand Hall B, Lobby Level

Oren Hannun Levine, MD
McMaster University
Hamilton, Ontario, Canada

 

Abstract 154:
Defining the elements of early palliative care (PC) that are associated with patient-reported outcomes (PROs) and the delivery of end-of-life (EOL) care.

Oral Abstract Session A
Friday, October 27, 2017: 10:00 - 10:10 a.m. PT,          
Manchester Grand Hyatt, Harbor Ballroom D,
Harbor Tower, 2nd Floor

Michael Hoerger, PhD, MS
Tulane Cancer Center,
Tulane University School of Medicine
New Orleans, Louisiana

 

Abstract 191:
A multimodal intervention to enhance sexual function and quality of life (QOL) in hematopoietic stem cell transplant (HCT) survivors.

Poster Session B
Saturday, October 28, 2017: 7:00 - 7:55 a.m. PT,
Saturday, October 28, 2017: 11:45 a.m. - 1:15 p.m. PT          
Manchester Grand Hyatt, Grand Hall B, Lobby Level

Areej El-Jawahri, MD
Massachusetts General Hospital
Boston, Massachusetts

 

Abstract 229:
Cranial electrotherapy stimulation for the management of depression, anxiety, sleep disturbance, and pain in patients with advanced cancer: A preliminary study.

Poster Session A
Friday, October 27, 2017: 11:30 a.m. - 1:30 p.m. PT,          
Friday, October 27, 2017: 5:15 - 6:15 p.m. PT
Manchester Grand Hyatt, Grand Hall B, Lobby Level

Sriram Yennu, MD
University of Texas MD Anderson Cancer Center
Houston, Texas

 

Abstract 230:
Randomized trial of a smartphone mobile app for adherence to oral chemotherapy.

Poster Session A
Friday, October 27, 2017: 11:30 a.m. - 1:00 p.m. PT,          
Friday, October 27, 2017: 5:15 - 6:15 p.m. PT
Manchester Grand Hyatt, Grand Hall B, Lobby Level

Jamie M. Jacobs, PhD
Harvard Medical School
Boston, Massachusetts

 

2017 Palliative and Supportive Care in Oncology Symposium News Planning Team:
Joseph Rotella, MD, MBA, HMDC, FAAHPM, American Academy of Hospice and Palliative Medicine (AAHPM); Andrew S. Epstein, MD, American Society of Clinical Oncology (ASCO); and David Warr, MD, FRCP, Multinational Association of Supportive Care in Cancer (MASCC).

Click here to view the disclosures for the News Planning Team.

ATTRIBUTION TO THE 2017 PALLIATIVE AND SUPPORTIVE CARE IN ONCOLOGY SYMPOSIUM IS REQUESTED IN ALL NEWS COVERAGE.

###
 

About the American Academy of Hospice and Palliative Medicine:
The American Academy of Hospice and Palliative Medicine AAHPM) is the only national medical specialty society for hospice and palliative medicine. Since 1988, AAHPM has supported hospice and palliative medicine through professional education and training, development of a specialist workforce, support for clinical practice standards, research, and public policy advocacy. AAHPM’s membership includes 5,000 physicians and other healthcare professionals committed to improving the care of patients with serious illness. Learn more at www.aahpm.org or visit our patient website, www.PalliativeDoctors.org. Follow us on Twitter, Facebook, LinkedIn and YouTube.

About ASCO: 

Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents more than 40,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at www.ASCO.org, explore patient education resources at www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube.

About the American Society for Radiation Oncology:
The American Society for Radiation Oncology (ASTRO) is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologist, physicists, radiation therapists, dosimetrists and other health care professionals that specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, the Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes three medical journals, International Journal of Radiation Oncology, Biology, PhysicsPractical Radiation Oncology, and Advances in Radiation Oncology, developed and maintains an extensive patient website; and created the Radiation Oncology Institute, a non-profit foundation to support research and education efforts around the world that enhance and confirm the critical role of radiation therapy in improving cancer treatment. 

About the Multinational Association of Supportive Care in Cancer:
The Multinational Association of Supportive Care in Cancer (MASCC) is an international, multidisciplinary organization with members from six continents and nearly 70 countries. It operates in collaboration with the International Society of Oral Oncology (ISOO). Founded in 1990, MASCC is dedicated to research and education in all areas of supportive care for patients with cancer, regardless of the stage of the disease. MASCC promotes professional expertise in supportive care through research and the scientific exchange of ideas. A focus on supportive care leads to better treatment outcomes and greater quality of life for people with cancer.